Financhill
Sell
48

PBR Quote, Financials, Valuation and Earnings

Last price:
$13.06
Seasonality move :
5.2%
Day range:
$12.96 - $13.17
52-week range:
$12.77 - $17.91
Dividend yield:
18.39%
P/E ratio:
5.13x
P/S ratio:
0.86x
P/B ratio:
1.16x
Volume:
15.2M
Avg. volume:
16.6M
1-year change:
-15.76%
Market cap:
$84B
Revenue:
$102.4B
EPS (TTM):
$2.54
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $76.6B $53.7B $84B $124.5B $102.4B
Revenue Growth (YoY) -9.51% -29.91% 56.41% 48.24% -17.73%
 
Cost of Revenues $45.7B $29.2B $43.2B $59.5B $48.4B
Gross Profit $30.9B $24.5B $40.8B $65B $54B
Gross Profit Margin 40.29% 45.62% 48.59% 52.21% 52.7%
 
R&D Expenses $576M $355M $563M $792M $726M
Selling, General & Admin $7.3B $4.5B $6.8B $7B $8.3B
Other Inc / (Exp) -$2.6B -$14.6B $1.9B $3.1B -$468M
Operating Expenses $9.9B $4.4B $9.8B $11.7B $14.7B
Operating Income $20.9B $20.1B $31B $53.3B $39.3B
 
Net Interest Expenses $6.3B $5.7B $4.6B $2.8B $3.4B
EBT. Incl. Unusual Items $12B -$226M $28.2B $53.5B $35.4B
Earnings of Discontinued Ops. $2.6B -- -- -- --
Income Tax Expense $4.2B -$1.2B $8.2B $16.8B $10.4B
Net Income to Company $10.4B $948M $20B $36.8B $25B
 
Minority Interest in Earnings -$212M $193M -$111M -$132M -$111M
Net Income to Common Excl Extra Items $10.2B $1.1B $19.9B $36.6B $24.9B
 
Basic EPS (Cont. Ops) $1.56 $0.18 $3.04 $5.62 $3.82
Diluted EPS (Cont. Ops) $1.56 $0.18 $3.04 $5.62 $3.82
Weighted Average Basic Share $6.5B $6.5B $6.5B $6.5B $6.5B
Weighted Average Diluted Share $6.5B $6.5B $6.5B $6.5B $6.5B
 
EBITDA $33.5B $17B $44.9B $70.1B $52.3B
EBIT $18.7B $5.5B $33.2B $56.8B $39B
 
Revenue (Reported) $76.6B $53.7B $84B $124.5B $102.4B
Operating Income (Reported) $20.9B $20.1B $31B $53.3B $39.3B
Operating Income (Adjusted) $18.7B $5.5B $33.2B $56.8B $39B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $13.1B $23.3B $32.4B $25.6B $23.4B
Revenue Growth (YoY) -32.28% 76.87% 39.37% -21.16% -8.56%
 
Cost of Revenues $6.9B $11.9B $15.9B $12B $11.4B
Gross Profit $6.3B $11.4B $16.5B $13.6B $12B
Gross Profit Margin 47.76% 48.99% 51.02% 53.11% 51.38%
 
R&D Expenses $92M $151M $187M $186M $195M
Selling, General & Admin $1.5B $2.1B $1.3B $2B $2.1B
Other Inc / (Exp) -$2.6B $530M -$1.2B -$1.4B $154M
Operating Expenses $2.8B $3B $2.1B $3.4B $3.3B
Operating Income $3.5B $8.4B $14.5B $10.2B $8.7B
 
Net Interest Expenses $1.7B $1.1B $615M $1B $753M
EBT. Incl. Unusual Items -$825M $7.8B $12.7B $7.7B $8.1B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$568M $1.9B $3.9B $2.3B $2.2B
Net Income to Company -$257M $6B $8.8B $5.5B --
 
Minority Interest in Earnings $21M -$16M -$27M -$28M -$21M
Net Income to Common Excl Extra Items -$236M $5.9B $8.8B $5.5B $5.9B
 
Basic EPS (Cont. Ops) -$0.04 $0.92 $1.34 $0.84 $0.90
Diluted EPS (Cont. Ops) -$0.04 $0.92 $1.34 $0.84 $0.90
Weighted Average Basic Share $6.5B $6.5B $6.5B $6.5B $6.4B
Weighted Average Diluted Share $6.5B $6.5B $6.5B $6.5B $6.4B
 
EBITDA $3.8B $12.1B $16.7B $12.3B $12B
EBIT $943M $9B $13.5B $8.8B $9B
 
Revenue (Reported) $13.1B $23.3B $32.4B $25.6B $23.4B
Operating Income (Reported) $3.5B $8.4B $14.5B $10.2B $8.7B
Operating Income (Adjusted) $943M $9B $13.5B $8.8B $9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $59.6B $73.8B $118.3B $105.5B $97.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $33.7B $36.1B $57.3B $51.6B $47.1B
Gross Profit $26B $37.8B $61B $53.9B $50.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $401M $515M $761M $691M $785M
Selling, General & Admin $6.1B $3.9B $6.4B $8B $9.7B
Other Inc / (Exp) -$24.5B $7.7B $2.2B $1.6B -$5B
Operating Expenses $8.8B $5.6B $10.2B $13.8B $17.3B
Operating Income $17.2B $32.2B $50.8B $40.1B $33.4B
 
Net Interest Expenses $5.4B $5.2B $2.7B $3.4B $5.4B
EBT. Incl. Unusual Items -$12.7B $34.6B $50.2B $38.4B $22.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$4.1B $8.7B $16B $11.4B $6.3B
Net Income to Company -$8.6B $25.9B $34.2B $27B --
 
Minority Interest in Earnings $207M -$179M -$141M -$119M -$86M
Net Income to Common Excl Extra Items -$8.4B $25.7B $34B $26.9B $16.6B
 
Basic EPS (Cont. Ops) -$1.28 $3.94 $5.20 $4.13 $2.54
Diluted EPS (Cont. Ops) -$1.28 $3.94 $5.20 $4.13 $2.54
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $5.8B $51.2B $66.3B $54.9B $33.8B
EBIT -$7.1B $40.1B $53.5B $42B $26.8B
 
Revenue (Reported) $59.6B $73.8B $118.3B $105.5B $97.7B
Operating Income (Reported) $17.2B $32.2B $50.8B $40.1B $33.4B
Operating Income (Adjusted) -$7.1B $40.1B $53.5B $42B $26.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $39.8B $59.9B $94.3B $75.3B $70.6B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $22.8B $29.7B $43.9B $36B $34.6B
Gross Profit $17B $30.2B $50.4B $39.3B $36B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $255M $415M $613M $512M $571M
Selling, General & Admin $5B $4.8B $4.4B $5.7B $7.2B
Other Inc / (Exp) -$21B $487M $808M -$67M -$4.9B
Operating Expenses $6.2B $6.5B $7B $9.6B $11.9B
Operating Income $10.8B $23.7B $43.4B $29.7B $24.1B
 
Net Interest Expenses $4.3B $3.9B $2B $2.5B $4.5B
EBT. Incl. Unusual Items -$14.6B $20.3B $42.2B $27.1B $14.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$3.9B $6B $13.8B $8.4B $4.3B
Net Income to Company -$10.7B $14.3B $28.5B $18.7B --
 
Minority Interest in Earnings $301M -$71M -$101M -$88M -$63M
Net Income to Common Excl Extra Items -$10.4B $14.2B $28.4B $18.6B $10.3B
 
Basic EPS (Cont. Ops) -$1.58 $2.18 $4.34 $2.87 $1.58
Diluted EPS (Cont. Ops) -$1.58 $2.18 $4.34 $2.87 $1.58
Weighted Average Basic Share $19.6B $19.6B $19.6B $19.6B $19.3B
Weighted Average Diluted Share $19.6B $19.6B $19.6B $19.6B $19.3B
 
EBITDA -$965M $33.2B $54.6B $39.5B $21B
EBIT -$10.2B $24.4B $44.7B $29.8B $17.6B
 
Revenue (Reported) $39.8B $59.9B $94.3B $75.3B $70.6B
Operating Income (Reported) $10.8B $23.7B $43.4B $29.7B $24.1B
Operating Income (Adjusted) -$10.2B $24.4B $44.7B $29.8B $17.6B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $7.4B $11.7B $10.5B $8B $12.7B
Short Term Investments $888M $659M $650M $2.8B $2.8B
Accounts Receivable, Net $3.8B $4.7B $6.4B $5B $6.1B
Inventory $8.2B $5.7B $7.3B $8.8B $7.7B
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.5B $1.2B $1.6B $1.8B $1.6B
Total Current Assets $27.8B $27.4B $30.1B $31.3B $32.4B
 
Property Plant And Equipment $159.3B $124.2B $125.3B $130.2B $153.4B
Long-Term Investments $5.6B $3.3B $1.6B $3.1B $3.8B
Goodwill $63M $24M $22M $24M $25M
Other Intangibles $19.4B $14.9B $3B $3B $3B
Other Long-Term Assets $9.7B $7.9B $8.5B $12.6B $17.1B
Total Assets $229.7B $190B $174.3B $187.2B $217.1B
 
Accounts Payable $5.6B $6.9B $5.5B $5.5B $4.8B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $4.5B $4.2B $3.6B $3.6B $4.3B
Current Portion Of Capital Lease Obligations $5.7B $5.7B $5.4B $5.6B $7.2B
Other Current Liabilities $5.2B $2.3B $2.7B $4.5B $3.6B
Total Current Liabilities $28.8B $26.2B $24.2B $31.4B $33.9B
 
Long-Term Debt $58.8B $49.7B $32.1B $26.4B $24.5B
Capital Leases -- -- -- -- --
Total Liabilities $155.5B $130.1B $104.5B $117.4B $138.1B
 
Common Stock $107.1B $107.1B $107.1B $107.1B $107.1B
Other Common Equity Adj -$33.8B -$47.8B -$37.7B -$37.6B -$28.5B
Common Equity $73.3B $59.3B $69.4B $69.5B $78.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $892M $528M $405M $344M $392M
Total Equity $74.2B $59.9B $69.8B $69.8B $79B
 
Total Liabilities and Equity $229.7B $190B $174.3B $187.2B $217.1B
Cash and Short Terms $8.3B $12.4B $11.1B $10.8B $15.5B
Total Debt $63.3B $53.9B $35.7B $30B $28.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $12.7B $10.9B $4.4B $12.1B $8.7B
Short Term Investments $670M $537M $2.4B $1.3B $5.6B
Accounts Receivable, Net $2.3B $4.7B $4.1B $5.1B $4.4B
Inventory $5.3B $7.3B $9.8B $7.9B $7.4B
Prepaid Expenses -- -- -- -- --
Other Current Assets $985M $1.8B $2.1B $1.8B $1.8B
Total Current Assets $26.9B $30.6B $29.5B $29.4B $30.7B
 
Property Plant And Equipment $104.7B $129.4B $124.1B $144.9B $141.1B
Long-Term Investments $3.1B $1.9B $1.7B $5.3B $1.6B
Goodwill -- -- $23M -- $23M
Other Intangibles -- -- $2.8B -- $2.5B
Other Long-Term Assets $7.3B $8.3B $11B $15.5B $15.8B
Total Assets $171.2B $179.2B $175.3B $204.8B $197.8B
 
Accounts Payable $4.3B $5.4B $5.2B $4.7B $5.3B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $6.7B $3.4B $3.3B $4.4B $4B
Current Portion Of Capital Lease Obligations $5.4B $5.7B $5.3B $6.6B $7.7B
Other Current Liabilities $2.2B $2.6B $4.6B $2.9B $3.2B
Total Current Liabilities $24.9B $25.5B $25.1B $30.9B $32.8B
 
Long-Term Debt $50.9B $33.3B $27.5B $25.1B $21.8B
Capital Leases -- -- -- -- --
Total Liabilities $126.8B $110.1B $106.1B $127.4B $125.3B
 
Common Stock $107.1B $107.1B $107.1B $107.1B $107.1B
Other Common Equity Adj -$63.2B -$39.3B -$38.2B -$30B -$41.3B
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -$197M --
Minority Interest, Total $465M $1.2B $297M $297M $257M
Total Equity $44.4B $69.1B $69.2B $77.4B $72.5B
 
Total Liabilities and Equity $171.2B $179.2B $175.3B $204.8B $197.8B
Cash and Short Terms $13.4B $11.5B $6.8B $13.4B $14.3B
Total Debt $57.6B $36.7B $30.9B $29.5B $25.8B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $10.4B $948M $20B $36.8B $25B
Depreciation & Amoritzation -- $11.4B $11.7B $13.2B $13.3B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $2.2B $1M -$2.1B $355M $88M
Change in Inventories -$281M $724M -$2.3B -$1.2B $1.6B
Cash From Operations $25.6B $28.9B $37.8B $49.7B $43.2B
 
Capital Expenditures $23.9B $5.9B $6.3B $9.6B $12.1B
Cash Acquisitions -$7M -$942M -$24M -$27M -$24M
Cash From Investing -$1.7B -$4.5B $2.2B -$432M -$8B
 
Dividends Paid (Ex Special Dividend) -$1.9B -$1.4B -$13.1B -$37.7B -$19.7B
Special Dividend Paid
Long-Term Debt Issued $7.5B $17B $1.9B $2.9B $2.2B
Long-Term Debt Repaid -$32.5B -$31.6B -$27.2B -$14.8B -$10.5B
Repurchase of Common Stock -- -- -- -- -$735M
Other Financing Activities -$167M -$151M -$129M -$18M -$48M
Cash From Financing -$32.1B -$19.3B -$40.8B -$51.5B -$30.7B
 
Beginning Cash (CF) $13.9B $7.4B $11.7B $10.5B $8B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$8.2B $5.1B -$843M -$2.2B $4.6B
Ending Cash (CF) $7.4B $11.7B $10.5B $8B $12.7B
 
Levered Free Cash Flow $1.7B $23B $31.5B $40.1B $31.1B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$257M $6B $8.8B $5.5B --
Depreciation & Amoritzation -- -- -$6.6B $3.5B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $435M -$752M $672M -$588M --
Change in Inventories -$364M -$585M -$561M $52M --
Cash From Operations $8.6B $10.5B $12.1B $11.6B --
 
Capital Expenditures $1.1B $1.5B $1.9B $3.2B --
Cash Acquisitions -$1M -$4M -$1M -$5M --
Cash From Investing -$565M $4B -$720M -$2.8B --
 
Dividends Paid (Ex Special Dividend) -- -$4B -$21.2B -$4.8B --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $101M $86M $2.2B $1.2B --
Long-Term Debt Repaid -$13.8B -$8.4B -$3.6B -$2.6B --
Repurchase of Common Stock -- -- -- -$197M --
Other Financing Activities -$47M -$33M $50M -$52M --
Cash From Financing -$14.7B -$13B -$23.2B -$7B --
 
Beginning Cash (CF) $19.5B $9.8B $16.3B $10.4B --
Foreign Exchange Rate Adjustment -$102M -$394M -$108M $81M --
Additions / Reductions -$6.7B $1.5B -$11.8B $1.7B --
Ending Cash (CF) $12.7B $10.9B $4.4B $12.1B --
 
Levered Free Cash Flow $7.5B $9B $10.1B $8.4B --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$8.6B $25.9B $34.2B $27B --
Depreciation & Amoritzation -- -- -- $22.9B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$611M -$1.4B $141M $213M --
Change in Inventories $327M -$2.2B -$2.8B $2.5B --
Cash From Operations $29.2B $35.7B $46.1B $44.4B $41.4B
 
Capital Expenditures $23B $6B $7.7B $12.1B $3.6B
Cash Acquisitions -$926M -$16M -$29M -$29M -$2M
Cash From Investing -$12B $1.3B $2.5B -$7.1B --
 
Dividends Paid (Ex Special Dividend) -$1.6B -$6.2B -$40.9B -$19.3B -$4.4B
Special Dividend Paid
Long-Term Debt Issued $18.6B $2.9B $2.7B $1.7B --
Long-Term Debt Repaid -$31.7B -$32.5B -$14.2B -$9.9B --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$138M -$135M -$68M -$143M --
Cash From Financing -$18.2B -$38.3B -$54.3B -$29.9B --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$972M -$1.4B -$5.8B $7.4B --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $6.2B $29.6B $38.4B $32.3B --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$10.7B $14.3B $28.5B $18.7B --
Depreciation & Amoritzation -- -- -- $9.6B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$69M -$1.5B $729M $587M --
Change in Inventories $742M -$2.2B -$2.6B $1.1B --
Cash From Operations $21.8B $28.6B $36.9B $31.5B --
 
Capital Expenditures $4.5B $4.6B $6B $8.5B --
Cash Acquisitions -$941M -$15M -$20M -$22M --
Cash From Investing -$4.2B $1.6B $1.9B -$4.7B --
 
Dividends Paid (Ex Special Dividend) -$1B -$5.8B -$33.7B -$15.2B --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $15.9B $1.8B $2.5B $1.3B --
Long-Term Debt Repaid -$24B -$24.9B -$11.8B -$7B --
Repurchase of Common Stock -- -- -- -$197M --
Other Financing Activities -$102M -$86M -$25M -$150M --
Cash From Financing -$11.9B -$30.9B -$44.4B -$22.8B --
 
Beginning Cash (CF) $42.3B $33.5B $44B $28.6B --
Foreign Exchange Rate Adjustment -$446M -$94M -$482M $127M --
Additions / Reductions $5.8B -$706M -$5.6B $4B --
Ending Cash (CF) $47.6B $32.7B $37.9B $32.8B --
 
Levered Free Cash Flow $17.3B $24B $30.8B $23B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 14.24% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 22.5% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 2.2% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock